NO147382C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte aminosyrer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte aminosyrer

Info

Publication number
NO147382C
NO147382C NO781892A NO781892A NO147382C NO 147382 C NO147382 C NO 147382C NO 781892 A NO781892 A NO 781892A NO 781892 A NO781892 A NO 781892A NO 147382 C NO147382 C NO 147382C
Authority
NO
Norway
Prior art keywords
fluorated
preparation
amino acids
therapeutic active
analogy procedure
Prior art date
Application number
NO781892A
Other languages
English (en)
Norwegian (no)
Other versions
NO781892L (no
NO147382B (no
Inventor
Janos Kollonitsch
Arthur Allan Patchett
Stephen Marburg
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/802,391 external-priority patent/US4325961A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO781892L publication Critical patent/NO781892L/no
Publication of NO147382B publication Critical patent/NO147382B/no
Publication of NO147382C publication Critical patent/NO147382C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
NO781892A 1977-06-01 1978-05-31 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte aminosyrer NO147382C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80238977A 1977-06-01 1977-06-01
US05/802,391 US4325961A (en) 1977-06-01 1977-06-01 Fluorinated amino acids

Publications (3)

Publication Number Publication Date
NO781892L NO781892L (no) 1978-12-04
NO147382B NO147382B (no) 1982-12-20
NO147382C true NO147382C (no) 1983-03-30

Family

ID=27122442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO781892A NO147382C (no) 1977-06-01 1978-05-31 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte aminosyrer

Country Status (26)

Country Link
JP (1) JPS5416423A (es)
AR (1) AR223463A1 (es)
AT (1) AT360509B (es)
AU (1) AU518479B2 (es)
CA (1) CA1120040A (es)
CH (1) CH639639A5 (es)
DD (1) DD138651A5 (es)
DE (1) DE2824116A1 (es)
DK (1) DK149841C (es)
ES (1) ES470296A1 (es)
FI (1) FI66840C (es)
FR (1) FR2392958A1 (es)
GB (1) GB1602525A (es)
GR (1) GR64495B (es)
HK (1) HK18184A (es)
HU (1) HU181911B (es)
IE (1) IE46983B1 (es)
IT (1) IT1104709B (es)
LU (1) LU79750A1 (es)
NL (1) NL190485C (es)
NO (1) NO147382C (es)
NZ (1) NZ187377A (es)
PL (1) PL115731B1 (es)
PT (1) PT68102B (es)
SE (1) SE7806440L (es)
YU (1) YU129178A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59481A0 (en) * 1977-07-11 1980-05-30 Merrell Toraude & Co -halomethyl amino acids
CA1091661A (en) * 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
ZA783273B (en) * 1977-07-11 1979-06-27 Merrell Toraude & Co A-halomethyl amino acids
US4315095A (en) * 1977-07-28 1982-02-09 Merrell Toraude Et Compagnie α-Halomethyl derivatives of amino acids
DE2965364D1 (en) * 1978-07-24 1983-06-16 Merck & Co Inc Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
IE49522B1 (en) * 1979-04-26 1985-10-16 Merrell Toraude & Co Alpha-halomethylaminoacids
IL60591A (en) * 1979-07-26 1985-02-28 Merrell Toraude & Co Alkenyl fluoromethyl ketimine magnesium halides and process for their preparation
ZA813018B (en) * 1980-05-09 1982-05-26 Merrell Toraude & Co Fluoromethylated tyrosine methyl ester
ZA813953B (en) * 1980-06-16 1982-06-30 Merrell Dow Pharma Method of inhibiting the growth of protozoa
US4421767A (en) * 1981-06-01 1983-12-20 Merrell Toraude Et Compagnie Compounds and methods for treating depression
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3046300A (en) * 1960-10-21 1962-07-24 Merck & Co Inc alpha-trifluoromethyloxyphenylalanines

Also Published As

Publication number Publication date
GR64495B (en) 1980-03-31
AR223463A1 (es) 1981-08-31
IE781078L (en) 1978-12-01
AU3658678A (en) 1979-12-06
DE2824116C2 (es) 1989-04-27
NL190485B (nl) 1993-10-18
AT360509B (de) 1981-01-12
FI66840B (fi) 1984-08-31
GB1602525A (en) 1981-11-11
DK149841B (da) 1986-10-13
LU79750A1 (fr) 1979-02-02
PT68102B (en) 1982-06-08
NL7805981A (nl) 1978-12-05
FR2392958B1 (es) 1980-10-24
NZ187377A (en) 1981-05-15
FR2392958A1 (fr) 1978-12-29
HU181911B (en) 1983-11-28
DE2824116A1 (de) 1978-12-14
ATA393278A (de) 1980-06-15
DD138651A5 (de) 1979-11-14
NO781892L (no) 1978-12-04
DK237978A (da) 1979-01-19
JPS5416423A (en) 1979-02-07
IE46983B1 (en) 1983-11-16
CH639639A5 (en) 1983-11-30
FI66840C (fi) 1984-12-10
HK18184A (en) 1984-03-09
FI781674A (fi) 1978-12-02
PL115731B1 (en) 1981-04-30
CA1120040A (en) 1982-03-16
NO147382B (no) 1982-12-20
PT68102A (en) 1978-06-01
SE7806440L (sv) 1978-12-02
JPS641474B2 (es) 1989-01-11
AU518479B2 (en) 1981-10-01
NL190485C (nl) 1994-03-16
IT7849637A0 (it) 1978-05-31
IT1104709B (it) 1985-10-28
PL207242A1 (pl) 1979-04-23
ES470296A1 (es) 1979-09-16
YU129178A (en) 1983-01-21
DK149841C (da) 1987-04-21

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO150397C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer
NO146428C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefiniske derivater av aminosyrer
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO151240C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
DK159967C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO147104C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive acetylenderivater av aminosyrer
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO147382C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte aminosyrer
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.